Duane Nash, Director at Akebia Therapeutics, Inc. (AKBA), sold 1,980 shares at $10.46 ($21K) on 2017-01-03, disclosed to the SEC on 2017-01-03.
Scheduled sale ($21k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IMUX | BUY | 2021-08-11 | $10K | — | Filing → |
| IMUX | BUY | 2021-05-12 | $51K | — | Filing → |
| IMUX | SELL | 2019-12-04 | $31K | — | Filing → |